EthOss Synthetic Bone Regeneration 3 x Syringes 0.5cc

EthOss contains no human or animal components and works with the patient's own body to maximise bone regeneration. In clinical trials, EthOss has shown outstanding results, with human biopsies typically showing 50% novo-bone at 12 weeks.

Born from a desire to move beyond traditional “GBR”, donor grafts and artificial scaffolds, EthOss® was created to pioneer True Host Bone Regeneration in dentistry and oral surgery. The initial concept was simple: “the body wants to heal, let’s work with it”. This was key to the development of EthOss - a grafting material which works with the body, upregulating the host healing response to regenerate lost bone. Founded by Dr Peter Fairbairn, a world-renowned clinician, and Dr Paul Harrison, a leading bone regeneration industry expert, the company has grown significantly since being founded in 2013 and is now a global brand.

• EthOss is a combination of Beta-Tri-Calcium Phosphate and Calcium Sulphate, creating an environment rich in phosphate and calcium ions, ideal for bone regrowth
• The Calcium Sulphate acts as a built-in barrier against soft tissue ingress, removing the need for an additional collagen membrane. This simplifies and expedites treatment
• Provides an ethical and highly effective solution for GBR, periodontitis, buccal defects, sinus grafts and extraction socket filling
• Helps new bone to grow quickly, with minimal discomfort and pain
• Over the course of treatment it will be completely replaced by the patient's own bone and it won't leave any remnants in their body
• Easily mixed into a paste with saline and applied using a simple syringe delivery system
• TGA Registration - ARTG Entry 299917
• Australian Prostheses Listing Billing Code - WB001
• Box of 3 x 0.5cc Syringes

>> Contact Our Team for Bulk Buys <<

Learn More About EthOss Bone Regeneration

Clinical Applications

EthOss® is intended to fill, augment, or reconstruct bony defects of the oral and maxillofacial region including:

• Infrabony Defects
• Alveolar Ridge Augmentation

• Dental Extraction Sites

Technical Information

• Composition - 65% beta tricalcium phosphate, (βTCP) Ca3(PO4)2, 35% calcium sulfate CaSO4
• Resorption Time - Full resorption usually over following 6-12 months.
• Mixing Agent - Standard sterile saline (0.9% Sodium Chloride) only
• Recommended Re-Entry Time - 12 weeks
• Sizes Available - 3 x 0.5cc, 3 x 1cc

Why ß-Tricalcium Phosphate ( ß -TCP )?

ß-TCP has been used medically for many years and is widely researched and trusted, with several benefits which make it particularly suitable for dentistry:

• Full resorption in line with the rate of new host bone formation
• Osteoconductive
• High osteoinductive potential with a large research base in this area
• Patient preference – no concerns over donor tissue or cross infection risks
• All ß-TCP is not the same – EthOss uses the latest generation of ß-TCP

Why Calcium Sulphate?

The oldest recorded biomaterial, Calcium Sulphate has been used in surgery for over 120 years. Whilst it does not possess the same bone regeneration capabilities as ß-TCP, Calcium  Sulphate brings one major benefit to the equation: it sets in situ, creating astable graft with an integrated cell-occlusive barrier. This helps prevent soft tissueingress, removing the need for a separate collagen membrane and giving the periosteum (and related blood supply) direct access to the graft site from day one.